The decline in Edwards Lifesciences' stock price is directly attributed to its Q1 financial performance and the guidance it provided. Typically, financial results and future guidance are critical factors that investors consider when assessing a company's health and future prospects. Negative reactions to such announcements can lead to a decrease in stock price, as seen with EW.